Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
about
Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.Noninferiority of 99mTc-Ethylenedicysteine-Glucosamine as an Alternative Analogue to 18F-Fluorodeoxyglucose in the Detection and Staging of Non-Small Cell Lung Cancer.The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death
P2860
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting the hexosamine biosy ...... diffuse large B-cell lymphoma.
@en
Targeting the hexosamine biosy ...... diffuse large B-cell lymphoma.
@nl
type
label
Targeting the hexosamine biosy ...... diffuse large B-cell lymphoma.
@en
Targeting the hexosamine biosy ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Targeting the hexosamine biosy ...... diffuse large B-cell lymphoma.
@en
Targeting the hexosamine biosy ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Targeting the hexosamine biosy ...... diffuse large B-cell lymphoma.
@en
P2093
Archito T Tamayo
David Yang
Ganiraju C Manyam
Jerry L Bryant
Ken H Young
L Jeffrey Medeiros
Lan V Pham
Richard J Ford
Richard Mendez
P2860
P304
80599-80611
P356
10.18632/ONCOTARGET.12413
P407
P577
2016-10-03T00:00:00Z